Association between the change in the number of non-ideal CVH metrics between baseline and year 1 and the subsequent risk of transition to hypertension
| . | Year 2 . | Year 3 . | Year 4 . | Year 5 . | ||||
|---|---|---|---|---|---|---|---|---|
| . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . |
| Unadjusted | 1.05 (1.01–1.09) | 1.13 (0.98–1.29) | 1.06 (1.03–1.09) | 1.07 (0.98–1.18) | 1.05 (1.02–1.07) | 1.08 (1.01–1.16) | 1.05 (1.03–1.08) | 1.06 (1.00–1.12) |
| Adjusted | 1.13 (1.09–1.18) | 1.21 (1.05–1.38) | 1.16 (1.12–1.19) | 1.19 (1.09–1.30) | 1.16 (1.13–1.19) | 1.21 (1.12–1.30) | 1.16 (1.13–1.19) | 1.19 (1.12–1.26) |
| . | Year 2 . | Year 3 . | Year 4 . | Year 5 . | ||||
|---|---|---|---|---|---|---|---|---|
| . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . |
| Unadjusted | 1.05 (1.01–1.09) | 1.13 (0.98–1.29) | 1.06 (1.03–1.09) | 1.07 (0.98–1.18) | 1.05 (1.02–1.07) | 1.08 (1.01–1.16) | 1.05 (1.03–1.08) | 1.06 (1.00–1.12) |
| Adjusted | 1.13 (1.09–1.18) | 1.21 (1.05–1.38) | 1.16 (1.12–1.19) | 1.19 (1.09–1.30) | 1.16 (1.13–1.19) | 1.21 (1.12–1.30) | 1.16 (1.13–1.19) | 1.19 (1.12–1.26) |
Abbreviations: CVH, cardiovascular health; HTN, hypertension. Unadjusted odds ratios (ORs) of 1-point increase in the number of non-ideal CVH metrics were adjusted for age, sex, blood pressure category (normal blood pressure or elevated blood pressure), and the number of non-ideal CVH metrics at the initial health check-up. ORs (95% confidence interval) were shown.
Association between the change in the number of non-ideal CVH metrics between baseline and year 1 and the subsequent risk of transition to hypertension
| . | Year 2 . | Year 3 . | Year 4 . | Year 5 . | ||||
|---|---|---|---|---|---|---|---|---|
| . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . |
| Unadjusted | 1.05 (1.01–1.09) | 1.13 (0.98–1.29) | 1.06 (1.03–1.09) | 1.07 (0.98–1.18) | 1.05 (1.02–1.07) | 1.08 (1.01–1.16) | 1.05 (1.03–1.08) | 1.06 (1.00–1.12) |
| Adjusted | 1.13 (1.09–1.18) | 1.21 (1.05–1.38) | 1.16 (1.12–1.19) | 1.19 (1.09–1.30) | 1.16 (1.13–1.19) | 1.21 (1.12–1.30) | 1.16 (1.13–1.19) | 1.19 (1.12–1.26) |
| . | Year 2 . | Year 3 . | Year 4 . | Year 5 . | ||||
|---|---|---|---|---|---|---|---|---|
| . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . | Stage 1 HTN . | Stage 2 HTN . |
| Unadjusted | 1.05 (1.01–1.09) | 1.13 (0.98–1.29) | 1.06 (1.03–1.09) | 1.07 (0.98–1.18) | 1.05 (1.02–1.07) | 1.08 (1.01–1.16) | 1.05 (1.03–1.08) | 1.06 (1.00–1.12) |
| Adjusted | 1.13 (1.09–1.18) | 1.21 (1.05–1.38) | 1.16 (1.12–1.19) | 1.19 (1.09–1.30) | 1.16 (1.13–1.19) | 1.21 (1.12–1.30) | 1.16 (1.13–1.19) | 1.19 (1.12–1.26) |
Abbreviations: CVH, cardiovascular health; HTN, hypertension. Unadjusted odds ratios (ORs) of 1-point increase in the number of non-ideal CVH metrics were adjusted for age, sex, blood pressure category (normal blood pressure or elevated blood pressure), and the number of non-ideal CVH metrics at the initial health check-up. ORs (95% confidence interval) were shown.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
